Comparison of the effects of deferasirox, deferiprone, and deferoxamine on the growth and virulence of Vibrio vulnificus
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Since deferoxamine (DFO), a standard iron‐chelating agent that is widely used in patients with iron overload such as hemochromatosis or thalassemia, is a kind of hydroxamine siderophore of Streptomyces species, it can accelerate the in vitro growth of ferophilic organisms such as Vibrio vulnificus, Yersinia enterocolitica, and Mucorales. STUDY DESIGN AND METHODS: We compared the effects of the two oral iron chelators, deferiprone (DFP) and deferasirox (DFS), on the growth and virulence of V. vulnificus with that of the parenteral iron‐chelating drug DFO used to treat patients with iron overload. RESULTS: When V. vulnificus ATCC 27562 was grown in iron‐poor liquid medium with α,α′‐dipryridyl, addition of DFO promoted its growth, whereas DFP and DFS did not. Only DFP and DFS showed growth inhibitory effect by chelating iron and causing iron deprivation. Similarly, on iron‐poor agar plates, various clinical V. vulnificus strains were only able to grow around filter paper disks impregnated with DFO. Our in vitro study data showed that DFS or DFP has more potential clinical application for preventing V. vulnificus infection in patients receiving iron chelation therapy. CONCLUSIONS: When patients with iron overload need iron chelation therapy, especially in a population at high risk for V. vulnificus in its endemic season, DFS or DFP may be safely used rather than DFO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of iron in the pathogenesis of Vibrio vulnificus infections
Wright, A. C., Simpson, L. M., & Oliver, J. D. (1981) · Infection and Immunity · doi:10.1128/iai.34.2.503-507.1981 · Cited by 343
The iron chelator deferasirox protects mice from mucormycosis through iron starvation
Ibrahim, A. S., Gebermariam, T., Fu, Y., Lin, Husseiny, M. I., French, S. W., Schwartz, J., Skory, C. D., Edwards, J. E., & Spellberg, B. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32338 · Cited by 308
Iron and infection: the heart of the matter
Bullen, J. J., Rogers, H. J., Spalding, P. B., & Ward, C. G. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.11.010 · Cited by 273
Iron: Mammalian defense systems, mechanisms of disease, and chelation therapy approaches
Kontoghiorghes, G. J., & Weinberg, E. D. (1995) · Blood Reviews · doi:10.1016/0268-960x(95)90038-1 · Cited by 134
Lesic, B., Foulon, J., & Carniel, E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1741-1745.2002 · Cited by 65
A Widespread Deferoxamine‐Mediated Iron‐Uptake System in Vibrio vulnificus
Kim, C., Park, Y., & Shin, S. (2007) · The Journal of Infectious Diseases · doi:10.1086/523108 · Cited by 49
Ferrophilic Characteristics of Vibrio vulnificus and Potential Usefulness of Iron Chelation Therapy
Kim, C., Park, R., Choi, M., Sun, H., & Shin, S. (2007) · The Journal of Infectious Diseases · doi:10.1086/509822 · Cited by 46 · cited 2×
“vulnificus can use DFO for efficient iron uptake via the outer membrane receptor DesA, encoded by the DesA gene, under iron-limited in vitro and ex vivo conditions.(7,17,18) V.”
Background
Cited by
Hod, E. A., Zhang, N., Sokol, S. A., Wojczyk, B. S., Francis, R. O., Ansaldi, D., Francis, K. P., Della-Latta, P., Whittier, S., Sheth, S., et al. (2010) · Blood · doi:10.1182/blood-2009-10-245001 · Cited by 485
Horseman, M. A., & Surani, S. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.11.003 · Cited by 343
Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity
Cassat, J. E., & Skaar, E. P. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0294-4 · Cited by 155
War-Fe-re: iron at the core of fungal virulence and host immunity
Nevitt, T. (2011) · BioMetals · doi:10.1007/s10534-011-9431-8 · Cited by 35
Neupane, G. P., & Kim, D.-M. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0875-5 · Cited by 29
Self-citation
Metadata
- Authors
- Neupane, G. P., & Kim, D.
- Venue
- Transfusion
- Publisher
- Wiley
- Published
- 2009-07-30
- Volume
- 49
- Issue
- 8
- Pages
- 1762-1769
- ISSN
- 0041-1132 (ISSN-L)
- 1537-2995
- OpenAlex
- W2019055169
- Cited by
- 42
- References
- 7
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of the effects of deferasirox, deferiprone, and deferoxamine on the growth and virulence of Vibrio vulnificus. https://app.cochat.ai/papers/10.1111/j.1537-2995.2009.02186.x
- The paper
- Neupane, G. P., & Kim, D. (2009). Comparison of the effects of deferasirox, deferiprone, and deferoxamine on the growth and virulence of Vibrio vulnificus. Transfusion. https://doi.org/10.1111/j.1537-2995.2009.02186.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.